Evogene Ltd.
A computational biology company using AI to develop life-science products.
EVGN | TA
Overview
Corporate Details
- ISIN(s):
- IL0011050551
- LEI:
- Country:
- Israel
- Address:
- 13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
- Website:
- https://evogene.com/
Description
Evogene Ltd. is a computational biology company that leverages artificial intelligence and big data to discover and develop novel life-science products. The company's proprietary Computational Predictive Biology (CPB) platform is designed to optimize the probability of success and reduce the time and cost of development. Evogene operates in the fields of human health, agriculture, and industrial applications. Its technology is organized into three AI-driven engines tailored for specific product types: MicroBoost AI for microbe-based products, ChemPass AI for small molecule-based products, and GeneRator AI for products based on genetic elements. The company's business model involves supporting subsidiary companies that focus on specific commercial fields, utilizing Evogene's technology to bring innovative products to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-10 16:00 |
Evogene Announces Completion of First-In-Class Foundation Model for Generative …
|
English | 621.6 KB | ||
| 2025-06-10 16:00 |
Evogene Announces Completion of First-In-Class Foundation Model for Generative …
|
English | 36.4 KB | ||
| 2025-06-06 01:00 |
Biomica- Update : Changes in management; Will significantly reduce its internal…
|
English | 81.0 KB | ||
| 2025-06-06 01:00 |
Biomica- Update : Changes in management; Will significantly reduce its internal…
|
English | 36.3 KB | ||
| 2025-05-21 16:00 |
Evogene Reports First Quarter 2025 Financial Results
|
English | 19.4 MB | ||
| 2025-05-21 16:00 |
Evogene Reports First Quarter 2025 Financial Results
|
English | 36.6 KB | ||
| 2025-05-08 16:00 |
will release its financial results for the first quarter of 2025, on May 21, 20…
|
English | 115.0 KB | ||
| 2025-05-08 16:00 |
will release its financial results for the first quarter of 2025, on May 21, 20…
|
English | 36.4 KB | ||
| 2025-04-21 16:00 |
ICL to Acquire the Activity of Evogene’s Subsidiary , Lavie Bio
|
English | 2.3 MB | ||
| 2025-04-21 16:00 |
ICL to Acquire the Activity of Evogene’s Subsidiary , Lavie Bio
|
English | 36.4 KB | ||
| 2025-03-28 14:54 |
POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-1
|
English | 447.7 KB | ||
| 2025-03-28 14:54 |
POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-1
|
English | 36.2 KB | ||
| 2025-03-28 14:53 |
FORM S-8-REGISTRATION STATEMENT UNDERTHE SECURITIES ACT OF 1933
|
English | 617.7 KB | ||
| 2025-03-28 14:53 |
FORM S-8-REGISTRATION STATEMENT UNDERTHE SECURITIES ACT OF 1933
|
English | 36.2 KB | ||
| 2025-03-28 00:40 |
20F FOR 2024
|
English | 8.3 MB |
Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evogene Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evogene Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
